Report on Grant of Stock Options (Board Resolution on May 6, 2026)

Creverse approved grant of 117,000 stock options to key personnel on May 6, 2026 via board resolution.
Exercise price: 10,880 won; closing price on grant date: 10,800 won; fair value per option: 703.70 won (binomial model, volatility 19.78%).
Exercise period: within 2 years after 3 years from grant date; cash-settled.
Subject to shareholder approval.

ADVERTISEMENT (250px+)